Literature DB >> 12084279

Management of vesicoureteral reflux in children.

S P Greenfield1.   

Abstract

Although much has been learned about the diagnosis and management of vesicoureteral reflux, several important areas of investigation remain. Because not all children with reflux are equally susceptible to renal scarring and the development of reflux nephropathy, controversy surrounds the need to evaluate all children with urinary tract infection or to continue prophylaxis in known refluxing children after a certain age. In addition to age, other factors such as sex, grade of reflux, and the presence of voiding dysfunction can all play a role. The grade of reflux as seen on the contrast voiding cystourethrogram is the best predictor of reflux resolution in large numbers of patients, but grade alone cannot predict spontaneous cessation in any one individual. Attempts at refining more quantitative imaging modalities have so far proved unsuccessful. Open ureteral reimplantation remains the standard for surgical care if surgery is necessary. Both cystoscopic and laparoscopic techniques, however, may ultimately prove to be reliable, minimally invasive approaches to definitive correction. Finally, there are data to support continued diagnosis and treatment of reflux in at-risk populations. The incidence of reflux-related morbidity in children has significantly diminished over the last three decades. A major challenge is to better identify at-risk subpopulations of children with reflux, so that not every child will require intensive, long-term medical treatment or surgery.

Entities:  

Mesh:

Year:  2001        PMID: 12084279     DOI: 10.1007/s11934-001-0007-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  72 in total

Review 1.  Relationship between dysfunctional voiding and reflux.

Authors:  S A Koff
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  Intermittent trimethoprim-sulfamethoxazole in children with vesicoureteral reflux.

Authors:  C Hori; M Hiraoka; H Tsukahara; S Tsuchida; M Sudo
Journal:  Pediatr Nephrol       Date:  1997-06       Impact factor: 3.714

3.  A follow-up study of pre-natally detected primary vesico-ureteric reflux: a review of 61 patients.

Authors:  H Bouachrine; J L Lemelle; F Didier; M Schmitt
Journal:  Br J Urol       Date:  1996-12

4.  Vesicoureteric reflux and renal scars in asymptomatic siblings of children with reflux.

Authors:  R B Kenda; J J Fettich
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

5.  Endoscopic treatment of reflux: migration of Teflon to the lungs and brain.

Authors:  I A Aaronson; R A Rames; W B Greene; L G Walsh; U A Hasal; P D Garen
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

Review 6.  Current status of the 'STING': an American perspective.

Authors:  I A Aaronson
Journal:  Br J Urol       Date:  1995-02

7.  Results of the renewed extravesical reimplant for surgical correction of vesicoureteral reflux.

Authors:  J Wacksman; A Gilbert; C A Sheldon
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

8.  Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-25

9.  Vesicoureteral reflux in infants under one year old. Follow-up study and consideration on development of renal scarring.

Authors:  M Arima; T Matsui; T Ogino; K Shimada; S Hosokawa; Y Mori; F Ikoma
Journal:  Urology       Date:  1993-04       Impact factor: 2.649

10.  Medical management of mild and moderate vesicoureteral reflux: followup studies of infants and young children. A preliminary report of the Southwest Pediatric Nephrology Study Group.

Authors:  B S Arant
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

View more
  1 in total

1.  Medical versus surgical management for vesicoureteric reflux: the case for medical management.

Authors:  Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.